ANIP logo

ANI Pharmaceuticals (ANIP) Operating profit

annual operating profit:

$2.22M-$47.31M(-95.52%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ANIP annual operating income is $2.22 million, with the most recent change of -$47.31 million (-95.52%) on December 31, 2024.
  • During the last 3 years, ANIP annual operating profit has risen by +$30.39 million (+107.87%).
  • ANIP annual operating profit is now -95.52% below its all-time high of $49.53 million, reached on December 31, 2023.

Performance

ANIP Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

quarterly operating profit:

$14.10M+$12.77M(+961.10%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP quarterly operating income is $14.10 million, with the most recent change of +$12.77 million (+961.10%) on March 31, 2025.
  • Over the past year, ANIP quarterly operating profit has dropped by -$953.00 thousand (-6.33%).
  • ANIP quarterly operating profit is now -8.39% below its all-time high of $15.39 million, reached on September 30, 2023.

Performance

ANIP quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

TTM operating profit:

$1.26M-$953.00K(-42.97%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP TTM operating income is $1.26 million, with the most recent change of -$953.00 thousand (-42.97%) on March 31, 2025.
  • Over the past year, ANIP TTM operating profit has dropped by -$51.33 million (-97.59%).
  • ANIP TTM operating profit is now -97.59% below its all-time high of $52.60 million, reached on March 31, 2024.

Performance

ANIP TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

ANIP Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-95.5%-6.3%-97.6%
3 y3 years+107.9%+176.5%+102.5%
5 y5 years-86.5%+279.8%-69.8%

ANIP Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-95.5%+107.9%-8.4%+171.6%-97.6%+102.3%
5 y5-year-95.5%+107.9%-8.4%+168.8%-97.6%+102.3%
alltimeall time-95.5%+104.4%-8.4%+156.8%-97.6%+102.3%

ANIP Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$14.10M(+961.1%)
$1.26M(-43.0%)
Dec 2024
$2.22M(-95.5%)
$1.33M(-106.7%)
$2.22M(-76.9%)
Sep 2024
-
-$19.69M(-456.3%)
$9.60M(-78.5%)
Jun 2024
-
$5.53M(-63.3%)
$44.69M(-15.0%)
Mar 2024
-
$15.05M(+72.8%)
$52.60M(+6.2%)
Dec 2023
$49.53M(-292.5%)
$8.71M(-43.4%)
$49.53M(+8.1%)
Sep 2023
-
$15.39M(+14.5%)
$45.83M(+55.6%)
Jun 2023
-
$13.44M(+12.1%)
$29.46M(+527.6%)
Mar 2023
-
$11.99M(+139.1%)
$4.69M(-118.2%)
Dec 2022
-$25.73M(-8.6%)
$5.01M(-612.5%)
-$25.73M(-49.8%)
Sep 2022
-
-$978.00K(-91.4%)
-$51.24M(-4.8%)
Jun 2022
-
-$11.33M(-38.6%)
-$53.83M(+8.4%)
Mar 2022
-
-$18.44M(-10.0%)
-$49.66M(+76.3%)
Dec 2021
-$28.17M(+80.9%)
-$20.50M(+475.5%)
-$28.17M(+308.7%)
Sep 2021
-
-$3.56M(-50.2%)
-$6.89M(+1203.0%)
Jun 2021
-
-$7.15M(-334.9%)
-$529.00K(-88.7%)
Mar 2021
-
$3.04M(+291.9%)
-$4.68M(-69.9%)
Dec 2020
-$15.57M(-194.8%)
$777.00K(-72.3%)
-$15.57M(-25.7%)
Sep 2020
-
$2.80M(-124.8%)
-$20.94M(+27.6%)
Jun 2020
-
-$11.31M(+44.2%)
-$16.42M(-492.6%)
Mar 2020
-
-$7.84M(+70.6%)
$4.18M(-74.5%)
Dec 2019
$16.43M(-53.5%)
-$4.60M(-162.7%)
$16.43M(-49.4%)
Sep 2019
-
$7.33M(-21.1%)
$32.47M(-7.9%)
Jun 2019
-
$9.29M(+111.1%)
$35.25M(+6.1%)
Mar 2019
-
$4.40M(-61.5%)
$33.22M(-6.0%)
Dec 2018
$35.36M(+21.0%)
$11.45M(+13.2%)
$35.36M(+9.8%)
Sep 2018
-
$10.11M(+39.3%)
$32.20M(+2.5%)
Jun 2018
-
$7.26M(+11.1%)
$31.41M(+0.9%)
Mar 2018
-
$6.54M(-21.1%)
$31.14M(+6.5%)
Dec 2017
$29.23M(+9.2%)
$8.28M(-11.2%)
$29.23M(+1.0%)
Sep 2017
-
$9.33M(+33.4%)
$28.93M(+5.1%)
Jun 2017
-
$6.99M(+51.2%)
$27.52M(+7.0%)
Mar 2017
-
$4.63M(-42.1%)
$25.72M(-3.9%)
Dec 2016
$26.76M(-18.2%)
$7.98M(+0.8%)
$26.76M(+6.8%)
Sep 2016
-
$7.92M(+52.5%)
$25.05M(-2.1%)
Jun 2016
-
$5.19M(-8.3%)
$25.58M(-11.2%)
Mar 2016
-
$5.67M(-9.6%)
$28.80M(-11.9%)
Dec 2015
$32.70M(+63.5%)
$6.27M(-25.8%)
$32.70M(-12.1%)
Sep 2015
-
$8.45M(+0.4%)
$37.20M(+0.7%)
Jun 2015
-
$8.41M(-12.1%)
$36.95M(+41.7%)
Mar 2015
-
$9.57M(-11.2%)
$26.08M(+30.4%)
Dec 2014
$20.01M(+2127.8%)
$10.77M(+31.4%)
$20.01M(+57.6%)
Sep 2014
-
$8.20M(-433.3%)
$12.69M(+139.3%)
Jun 2014
-
-$2.46M(-170.4%)
$5.30M(+33.0%)
Mar 2014
-
$3.50M(+1.0%)
$3.99M(-263.0%)
Dec 2013
$898.00K(-103.9%)
$3.46M(+327.2%)
-$2.45M(-74.4%)
Sep 2013
-
$810.00K(-121.5%)
-$9.54M(-39.2%)
Jun 2013
-
-$3.77M(+28.3%)
-$15.69M(-18.2%)
Mar 2013
-
-$2.94M(-19.1%)
-$19.18M(-17.2%)
Dec 2012
-$23.17M
-$3.64M(-31.9%)
-$23.17M(-17.0%)
Sep 2012
-
-$5.33M(-26.6%)
-$27.93M(-21.6%)
Jun 2012
-
-$7.27M(+4.9%)
-$35.62M(-14.0%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$6.93M(-17.4%)
-$41.42M(-18.7%)
Dec 2011
-$50.93M(+16.8%)
-$8.39M(-35.6%)
-$50.93M(-8.6%)
Sep 2011
-
-$13.03M(-0.3%)
-$55.70M(+3.3%)
Jun 2011
-
-$13.06M(-20.5%)
-$53.92M(+5.5%)
Mar 2011
-
-$16.44M(+24.9%)
-$51.09M(+17.2%)
Dec 2010
-$43.61M(+13.5%)
-$13.17M(+17.2%)
-$43.61M(-21.1%)
Sep 2010
-
-$11.24M(+9.8%)
-$55.28M(+13.0%)
Jun 2010
-
-$10.24M(+14.3%)
-$48.94M(+13.0%)
Mar 2010
-
-$8.96M(-63.9%)
-$43.32M(+12.7%)
Dec 2009
-$38.43M(+113.3%)
-$24.84M(+407.0%)
-$38.43M(+148.8%)
Sep 2009
-
-$4.90M(+6.0%)
-$15.44M(-10.4%)
Jun 2009
-
-$4.62M(+13.7%)
-$17.23M(-4.9%)
Mar 2009
-
-$4.06M(+118.5%)
-$18.13M(+0.5%)
Dec 2008
-$18.01M(+107.5%)
-$1.86M(-72.2%)
-$18.03M(-0.8%)
Sep 2008
-
-$6.69M(+21.3%)
-$18.18M(+33.3%)
Jun 2008
-
-$5.51M(+39.0%)
-$13.64M(+26.8%)
Mar 2008
-
-$3.97M(+97.1%)
-$10.76M(+24.0%)
Dec 2007
-$8.68M(-352.3%)
-$2.01M(-6.3%)
-$8.68M(-366.2%)
Sep 2007
-
-$2.15M(-18.4%)
$3.26M(-28.2%)
Jun 2007
-
-$2.63M(+39.3%)
$4.54M(-6.9%)
Mar 2007
-
-$1.89M(-119.0%)
$4.88M(+41.8%)
Dec 2006
$3.44M(-137.0%)
$9.93M(-1244.3%)
$3.44M(-141.5%)
Sep 2006
-
-$867.50K(-62.2%)
-$8.28M(-11.6%)
Jun 2006
-
-$2.30M(-31.0%)
-$9.37M(-4.0%)
Mar 2006
-
-$3.32M(+85.5%)
-$9.76M(+4.9%)
Dec 2005
-$9.30M(-24.2%)
-$1.79M(-8.4%)
-$9.30M(-20.6%)
Sep 2005
-
-$1.96M(-27.1%)
-$11.72M(-7.8%)
Jun 2005
-
-$2.68M(-6.4%)
-$12.72M(+0.4%)
Mar 2005
-
-$2.87M(-31.9%)
-$12.66M(+3.2%)
Dec 2004
-$12.27M(+102.9%)
-$4.21M(+42.5%)
-$12.27M(+25.1%)
Sep 2004
-
-$2.95M(+12.3%)
-$9.80M(+18.3%)
Jun 2004
-
-$2.63M(+6.4%)
-$8.29M(+13.8%)
Mar 2004
-
-$2.47M(+41.6%)
-$7.29M(+20.3%)
Dec 2003
-$6.05M(+58.7%)
-$1.75M(+21.4%)
-$6.06M(+28.3%)
Sep 2003
-
-$1.44M(-11.6%)
-$4.72M(+15.6%)
Jun 2003
-
-$1.63M(+30.8%)
-$4.08M(+3.2%)
Mar 2003
-
-$1.24M(+202.6%)
-$3.96M(+3.7%)
Dec 2002
-$3.81M(+36.8%)
-$411.40K(-48.6%)
-$3.82M(-21.2%)
Sep 2002
-
-$801.00K(-46.7%)
-$4.85M(+28.9%)
Jun 2002
-
-$1.50M(+36.2%)
-$3.76M(+20.6%)
Mar 2002
-
-$1.10M(-23.4%)
-$3.12M(+13.9%)
Dec 2001
-$2.79M(-19.0%)
-$1.44M(-603.1%)
-$2.73M(+34.1%)
Sep 2001
-
$286.30K(-133.3%)
-$2.04M(-32.2%)
Jun 2001
-
-$858.90K(+19.0%)
-$3.01M(-16.1%)
Mar 2001
-
-$722.00K(-3.0%)
-$3.58M(+6.1%)
Dec 2000
-$3.44M(+114.2%)
-$744.40K(+9.3%)
-$3.38M(+28.3%)
Sep 2000
-
-$680.90K(-52.5%)
-$2.63M(+34.9%)
Jun 2000
-
-$1.43M(+177.8%)
-$1.95M(+131.5%)
Mar 2000
-
-$516.20K(+58.2%)
-$842.40K(+158.2%)
Dec 1999
-$1.60M(-39.7%)
-
-
Jun 1999
-
-$326.20K
-$326.20K
Dec 1998
-$2.66M
-
-

FAQ

  • What is ANI Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual operating profit year-on-year change?
  • What is ANI Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly operating profit year-on-year change?
  • What is ANI Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals TTM operating profit year-on-year change?

What is ANI Pharmaceuticals annual operating income?

The current annual operating profit of ANIP is $2.22M

What is the all time high annual operating profit for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual operating income is $49.53M

What is ANI Pharmaceuticals annual operating profit year-on-year change?

Over the past year, ANIP annual operating income has changed by -$47.31M (-95.52%)

What is ANI Pharmaceuticals quarterly operating income?

The current quarterly operating profit of ANIP is $14.10M

What is the all time high quarterly operating profit for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly operating income is $15.39M

What is ANI Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, ANIP quarterly operating income has changed by -$953.00K (-6.33%)

What is ANI Pharmaceuticals TTM operating income?

The current TTM operating profit of ANIP is $1.26M

What is the all time high TTM operating profit for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high TTM operating income is $52.60M

What is ANI Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, ANIP TTM operating income has changed by -$51.33M (-97.59%)
On this page